The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
TREM2-Transduced Myeloid Precursors Mediate Nervous Tissue Debris Clearance and Facilitate Recovery in an Animal Model of Multiple Sclerosis
Open accessAbstract
BACKGROUND: In multiple sclerosis, inflammation can successfully be prevented, while promoting repair is still a major challenge. Microglial cells, the resident phagocytes of the central nervous system (CNS), are hematopoietic-derived myeloid cells and express the triggering receptor expressed on myeloid cells 2 (TREM2), an innate immune receptor. Myeloid cells are an accessible source for ex vivo gene therapy. We investigated whether myeloid precursor cells genetically modified to express TREM2 affect the disease course of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. METHODS AND FINDINGS: EAE was induced in mice by immunization with a myelin autoantigen. Intravenous application of TREM2-transduced bone marrow-derived myeloid precursor cells at the EAE peak led to an amelioration of clinical symptoms, reduction in axonal damage, and prevention of further demyelination. TREM2-transduced myeloid cells applied intravenously migrated into the inflammatory spinal cord lesions of EAE-diseased mice, showed increased lysosomal and phagocytic activity, cleared degenerated myelin, and created an anti-inflammatory cytokine milieu within the CNS. CONCLUSIONS: Intravenously applied bone marrow-derived and TREM2-tranduced myeloid precursor cells limit tissue destruction and facilitate repair within the murine CNS by clearance of cellular debris during EAE. TREM2 is a new attractive target for promotion of repair and resolution of inflammation in multiple sclerosis and other neuroinflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, the clearance of myelin debris by microglia is believed to be critically required to limit neuronal damage in EAE (Cignarella et al., 2020; Takahashi et al., 2007; Weinger et al., 2011).”
From SYK coordinates neuroprotective microglial responses in neurodegenerative disease (2022) · cites this paper as Takahashi et al., 2007
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“TREM2 promotes proliferation (119), survival (119), and phagocytosis of apoptotic cells (120–122).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552 · cited 1×
“Efficient removal of apoptotic cells and cellular debris by macrophages during acute injury or degenerative diseases is essential for repair of the damaged tissue, inflammation resolution, and disease recovery [11–13].”
BackgroundImmunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787 · cited 1×
“Efficient removal of apoptotic cells and cellular debris by macrophages during acute injury or degenerative diseases is essential for repair of the damaged tissue, inflammation resolution, and disease recovery [11–13].”
BackgroundA blast from the past: clearance of apoptotic cells regulates immune responses
Savill, J., Dransfield, I., Gregory, C., & Haslett, C. (2002) · Nature Reviews Immunology · doi:10.1038/nri957 · Cited by 1,574 · cited 1×
“Efficient removal of apoptotic cells and cellular debris by macrophages during acute injury or degenerative diseases is essential for repair of the damaged tissue, inflammation resolution, and disease recovery [11–13].”
BackgroundPerivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo
Hickey, W. F., & Kimura, H. (1988) · Science · doi:10.1126/science.3276004 · Cited by 1,466 · cited 1×
“Hematopoietic-derived myeloid cells physiologically migrate into the central nervous system (CNS) not only during development, but also in adulthood, and become resident perivascular macrophages and microglia [1–3].”
BackgroundTakahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 12×
“Recently, we discovered in vitro that the microglial triggering receptor expressed on myeloid cells-2 (TREM2) stimulates phagocytosis and down-regulates inflammatory signals in microglia via the signaling adaptor molecule DAP12 [14].”
BackgroundInfluentialSelf-citationYoussef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097 · cited 1×
“Most experimental approaches in EAE aim at skewing the cytokine profile of myelin-specific TH cells from TH1 to TH2 by altered peptide ligands [43,44], hydroxymethyl-glutaryl coenzyme A reductase inhibitors (‘‘statins’’) [45], or DNA vaccination combined with gene delivery of interleukin-4 (IL-4) [46].”
BackgroundInjection of adult neurospheres induces recovery in a chronic model of multiple sclerosis
Pluchino, S., Quattrini, A., Brambilla, E., Gritti, A., Salani, G., Dina, G., Galli, R., Del Carro, U., Amadio, S., Bergami, A., et al. (2003) · Nature · doi:10.1038/nature01552 · Cited by 1,068 · cited 1×
“Recently, brain-derived neurospheres have been injected intravenously and have been successfully used for cell therapy of EAE inducing repair and immunomodulatory activity [48,49], but these adult neural precursors are not a suitable cellular source for broad clinical applications.”
Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism
Pluchino, S., Zanotti, L., Rossi, B., Brambilla, E., Ottoboni, L., Salani, G., Martinello, M., Cattalini, A., Bergami, A., Furlan, R., et al. (2005) · Nature · doi:10.1038/nature03889 · Cited by 768
Experimental autoimmune encephalomyelitis repressed by microglial paralysis
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732 · cited 1×
“Furthermore, the microglial cytokine milieu determines the outcome of the inflammatory process in the animal model of MS, experimental autoimmune encephalomyelitis (EAE) [16–18].”
BackgroundSelf-citationTREMs in the immune system and beyond
Colonna, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1106 · Cited by 701 · cited 2×
“dendritic cells, and microglia [21].”
Research works printed but not linked: 49
- Hickey, 1988, Science, 239, 290
- Priller, 2001, Nat Med, 7, 1356
- Simard, 2004, FASEB J, 18, 998
- Flugel, 2001, J Neurosci Res, 66, 74
- Bechmann, 2005, FASEB J, 19, 647
- Malm, 2005, Neurobiol Dis, 18, 134
- Stalder, 2005, J Neurosci, 25, 11125
- Santambrogio, 2001, Proc Natl Acad Sci U S A, 98, 6295
- Servet-Delprat, 2002, BMC Immunol, 3, 15
- Asheuer, 2004, Proc Natl Acad Sci U S A, 101, 3557
- Voll, 1997, Nature, 390, 350
- Savill, 2002, Nat Rev Immunol, 2, 965
- Serhan, 2005, Nat Immunol, 6, 1191
- Takahashi, 2005, J Exp Med, 201, 647
- Prat, 2005, Curr Opin Neurol, 18, 225
- Carson, 2002, Glia, 40, 218
- Heppner, 2005, Nat Med, 11, 146
- Platten, 2005, Nat Med, 11, 252
- Willenbring, 2004, Nat Med, 10, 744
- Prinz, 2006, J Clin Invest, 116, 456
- Colonna, 2003, Nat Rev Immunol, 3, 445
- Matsuo, 1997, Am J Pathol, 150, 1253
- Paloneva, 2001, Neurology, 56, 1552
- Paloneva, 2003, J Exp Med, 198, 669
- Paloneva, 2002, Am J Hum Genet, 71, 656
- Schmid, 2002, J Neurochem, 83, 1309
- Cella, 2003, J Exp Med, 198, 645
- Turnbull, 2006, J Immunol, 177, 3520
- Bauer, 1994, J Neurosci Res, 38, 365
- Kotter, 2005, Neurobiol Dis, 18, 166
- Zhao, 2005, J Neurol Sci, 233, 87
- Schwab, 2004, Curr Opin Neurobiol, 14, 118
- Kerschensteiner, 2004, J Exp Med, 200, 1027
- Jander, 1998, Am J Pathol, 152, 975
- Bettelli, 1998, J Immunol, 161, 3299
- McGeachy, 2005, J Immunol, 175, 3025
- Cua, 2001, J Immunol, 166, 602
- Bakker, 2000, Immunity, 13, 345
- Steinman, 2001, Nat Immunol, 2, 762
- Zamvil, 2003, Neuron, 38, 685
- Arnold, 2005, J Neurol, 252, v25
- Lim, 2005, Mult Scler, 11, 532
- Evavold, 1993, Immunol Today, 14, 602
- Nicholson, 1995, Immunity, 3, 397
- Youssef, 2002, Nature, 420, 78
- Garren, 2001, Immunity, 15, 15
- Flugel, 2001, Eur J Immunol, 31, 11
- Pluchino, 2003, Nature, 422, 688
- Pluchino, 2005, Nature, 436, 266
Cited by
Items 301–400 of 414
TREM-2 negatively regulates LPS-mediated inflammatory response in rat bone marrow-derived MSCs
Ye, P., Xu, D., Xu, J., Liu, G., Huang, S. J., Zhang, W., Zheng, P., Li, J., & Huang, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7212 · Cited by 14
“Phosphorylated and total protein levels of AKT, p38 MAPK, ERK1/2 and NF-κ B in the Null MSCs and TREM-2 MSCs were examined by western blot analysis before and after LPS stimulation for 15 min (1 µg/ml) (Fig.”
InfluentialRikos, D., Siokas, V., Aloizou, A., Tsouris, Z., Aslanidou, P., Koutsis, G., Anagnostouli, M. C., Bogdanos, D. P., Grigoriadis, N., Hadjigeorgiou, G. M., et al. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.07.007 · Cited by 12
Cerebrospinal fluid biomarkers as predictors of multiple sclerosis severity
Tolentino, M., Pace, F., Perantie, D. C., Mikesell, R., Huecker, J., Chahin, S., Ghezzi, L., Piccio, L., & Cross, A. H. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106268 · Cited by 11
RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding Alzheimer’s Disease
Medd, M. M., Yon, J. E., & Dong, H. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47020124 · Cited by 12
“When membrane-bound, TREM2 binds to lipids and elicits essential neuroprotective effects by downregulating the expression of pro-inflammatory cytokines, such as TNF-α , IL-1 β , and NOS2, and upregulating the transcription of anti-inflammatory cytokines, including IL-4, IL-10, and IL-11 [201–203].”
Ansari, J. A., Dey, R. K., Mishra, S. K., Roy, O., Kushwaha, S., Singh, V., Patnaik, S., & Ghosh, D. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.06.009 · Cited by 11
Temporal-logic analysis of microglial phenotypic conversion with exposure to amyloid-β
Anastasio, T. J. (2014) · Molecular BioSystems · doi:10.1039/c4mb00457d · Cited by 13
Lysosomal Storage Disorders and Iron
Brás, J. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-410502-7.00012-0 · Cited by 11
Katsumoto, A., Kokiko‐Cochran, O. N., Bemiller, S. M., Xu, G., Ransohoff, R. M., & Lamb, B. T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.978423 · Cited by 12
TREM2 in Regulating Macrophage Inflammatory Responses and Disease Pathogenesis
Medd, M. M. (2024) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2024054889 · Cited by 13
Ju, W.-Y., Wang, Q., Song, L.-J., Ding, Z., Li, X., Kumar, G., Yan, Y., & Ma, C. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07968-z · Cited by 12
Greer, R. A., Tuckey, R. A., Dean, H. B., Brett, T. J., Roberson, E. D., & Song, Y. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70729 · Cited by 9
Involvement of IL-10R/STAT3 pathway in amyloid β clearance by microlgia in Alzheimer's disease
Liu, H., Zhou, Y., & Song, W. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108263 · Cited by 17
Gillespie, A., Teoh, J. J., Lee, H. J., Prince, J. L., Stadnisky, M. D., Anderson, M. R., Nash, W., Rival, C. M., Wei, H., Gamache, A., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005419 · Cited by 10
“As these molecules have been shown to regulate innate immune cells [45], inflammation [46,47], dead cell clearance [48,49] and disease [50– 53], they too represent interesting positional candidates.”
BackgroundCárdenas‐Tueme, M., Montalvo-Martínez, L., Maldonado‐Ruiz, R., Camacho‐Morales, A., & Reséndez‐Pérez, D. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00013 · Cited by 10
Schwarz, H., Bässler, S., Balta, D., Socher, E., Zunke, F., & Arnold, P. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113977 · Cited by 8
No evidence for shared etiology in two demyelinative disorders, MS and PLOSL
Sulonen, A.-M., Kallio, S. P., Ellonen, P., Suvela, M. H., Elovaara, I., Koivisto, K. J., Pirttilä, T., Reunanen, M., Tienari, P. J., Palotie, A. V., et al. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.10.005 · Cited by 9
“Interestingly, TREM2 overexpression has been observed to protect mice from autoimmune demyelination; when experimental autoimmune encephalomyelitis (EAE) mice were injected with TREM2-transduced myeloid precursor cells, the clinical symptoms of the mice alleviated, and there was less axonal damage in the mice CNS (Tak…”
BackgroundInfluentialPapenfuss, T. L., Thrash, J. C., Danielson, P. E., Foye, P. E., Hllbrush, B. S., Sutcliffe, J. G., Whitacre, C. C., & Carson, M. J. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.251 · Cited by 8
“Surprisingly, within the CNS, only microglia express detectable TREM2 mRNA[11,12].”
BackgroundDavis, D. S., & Carson, M. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_1 · Cited by 8
Que, X., Zhang, T., Liu, X. Y., Yin, Y., Xia, X., Gong, P., Song, W., Qin, Q., Xu, Q., & Tang, Y. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102732 · Cited by 8
“Overexpression of TREM2 promotes the clearance of degenerated myelin, inhibits the expression of pro-inflammatory molecules, and reduces further damage to intact myelin and axons (Takahashi et al., 2007).”
Ashraf, A., Aljuhani, M., Hubens, C. J., Jeandriens, J., Parkes, H. G., Geraki, K., Mahmood, A., Herlihy, A. H., & So, P. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1393351 · Cited by 11
Qiu, Z., Wang, H., Qu, M., Zhu, S., Zhang, H., Liao, Q., & Miao, C. (2023) · Brain Sciences · doi:10.3390/brainsci13010126 · Cited by 10
Targeting Myeloid Cells to the Brain Using Non-Myeloablative Conditioning
Böttcher, C., Fernández‐Klett, F., Gladow, N., Rolfes, S., & Priller, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080260 · Cited by 8
“Transplantation of genetically labelled BMDCs into total bodyirradiated hosts has demonstrated that circulating myeloid cells engraft in the CNS and contribute to the pool of brain macrophages, both in the absence and during overt brain pathology [6-21].”
BackgroundBACE1 influences debris clearance and axonal regeneration in injured peripheral nerve
Farah, M. H. (2012) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2012.00428.x · Cited by 8
“Additionally, mice transplanted with TREM2-transduced myeloid cells show improved phagocytosis and better clinical outcome in an experimental model of multiple sclerosis (Takahashi et al., 2007).”
BackgroundRezaie, P., & Hanisch, U. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1429-6_2 · Cited by 7
Study on pyroptosis-related genes Casp8, Gsdmd and Trem2 in mice with cerebral infarction
Liang, S., Xu, L., Xin, X., Zhang, R., & Wu, Y. (2024) · PeerJ · doi:10.7717/peerj.16818 · Cited by 6
“Trem2 improves the inflammatory response in vitro by inhibiting the secretion of cytokines by microglia ( Takahashi, Rochford & Neumann, 2005 ; Takahashi et al., 2007 ).”
Hodgson, L. M., Li, Y., Iturria‐Medina, Y., Stratton, J. A., Wolf, G., Krishnaswamy, S., Bennett, D. A., & Bzdok, D. (2024) · Communications Biology · doi:10.1038/s42003-024-06273-8 · Cited by 8
“It is known to modulate the rate of phagocytosis 24 and to modulate in fl amma-tory signaling 70 .”
BackgroundMyeloid cell-based therapies in neurological disorders: How far have we come?
Böttcher, C., & Priller, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.003 · Cited by 7
Pattern of triptans use: a retrospective prescription study in Calabria, Italy
Bagetta, G., Scuteri, D., Adornetto, A., Rombolà, L., Naturale, M., Francesco, A. D., Esposito, S., Zito, M., Morrone, L., Tonin, P., et al. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.266062 · Cited by 7
“…effects on many biological processes during peripheral nerve repair and Wallerian degeneration, including immune responses, macrophage recruitment and Schwann cell reprogramming (van der Laan et al., 1996; da Costa et al., 1997; Siebert et al., 2000; Takahashi et al., 2007; Clements et al., 2017).”
Microglia in Gliomas: Friend or Foe?
Kaminska, B. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1431-5_9 · Cited by 6
Pohland, M., Pohland, C., Kiwit, J., & Glumm, J. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.336873 · Cited by 6
“In contrast, TREM2-transduced myeloid precursors limited tissue destruction and promoted CNS repair (Takahashi et al., 2007) in experimental autoimmune encephalomyelitis, the animal model for MS.”
Background[Splenic cyst. Review of the literature and report of 2 cases].
de Melo, V. A., Júnior, A. A., Andrade, L. C., Aragão, J. F. B., & Rosa, J. E. (1995) · PubMed · Cited by 6
Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States
Kuhn, M. K., & Proctor, E. A. (2024) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26723 · Cited by 5
Kong, Y., Wang, D., Jin, X., Liu, Y., & Xu, H. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1334786 · Cited by 8
Neuroprotection Strategies for the Newborn
Juul, S. E., Fleiss, B., McAdams, R. M., & Gressèns, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40139-5.00062-0 · Cited by 6
Bibliometric Analysis of TREM2 (2001-2022): Trends, Hotspots and Prospects in Human Disease
Qian, M., Zhong, J., Lu, Z., Zhang, W., Weng, M., Zhang, K., & Jin, Y. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.96851 · Cited by 5
Picard, K., Dolhan, K., Watters, J. J., & Tremblay, M. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_20 · Cited by 7
Possible role of microgliopathy in the pathogenesis of Nasu–Hakola disease
Satoh, J. (2013) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12046 · Cited by 4
“In contrast, intravenous administration of TREM2-transduced myeloid cells promotes the recovery of EAE by facilitating the clearance of myelin debris.(21) In macrophages and dendritic cells, TREM2 negatively regulates toll-like receptor (TLR)mediated pro-inflammatory immune responses, showing an intrinsically anti-inf…”
BackgroundCandia, Y. A., Aladyeva, E., Boyden, W., Bollman, B., Rogerson‐Wood, L., Davies, D., Affleck, A. J., Buckland, M. E., Harari, O., Piccio, L. M., et al. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02241-x · Cited by 4
“Elevating TREM2 in peripheral monocytes facilitates tissue repair and remyelination in experimental autoimmune encephalomyelitis (EAE) [13].”
TREM2 deficiency alters acute macrophage distribution and improves recovery after TBI.
Saber, M., On, K.-C., Puntambekar, S. S., Lathia, J. D., & Lamb, B. T. (2016) · Journal of Neurotrauma · Cited by 3
An introduction to innate immunity in the central nervous system
Harry, G. J., Childers, G. M., & McPherson, C. A. (2018) · Advances in neurotoxicology · doi:10.1016/bs.ant.2018.10.002 · Cited by 4
Rezaie, P., & Hanisch, U. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_2 · Cited by 3
Perspectives of Stem Cell-Derived Microglia for Medicine
Roy, K., Beutner, C., & Neum, H. (2011) · InTech eBooks · doi:10.5772/13850 · Cited by 4
“Furthermore, an anti-inflammatory milieu is established in the lesion sites due to the treatment (Takahashi et al., 2007a).”
InfluentialGorenjak, V., Arguinano, A.-A. A., Dadé, S., Stathopoulou, M. G., Vance, D. R., Masson, C., & Visvikis‐Siest, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-25553-y · Cited by 5
When the Tail Can't Wag the Dog: The Implications of CNS-Intrinsic Initiation of Neuroinflammation
Davis, D. S., & Carson, M. J. (2009) · ASN NEURO · doi:10.1042/an20090024 · Cited by 3
“…which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. asnneuro.org / Volume 1 (2) / art:e00008 91 inflammatory immune responses (Takahashi et al., 2007; reviewed in Carson et al., 2006; Carson and Lo, 2007).”
BackgroundInfluentialMechanisms of Innate Immune Modulation by High-Fat Diet: Implications for Obesity and Asthma
Caslin, H. L., & Williams, J. W. (2025) · Current Allergy and Asthma Reports · doi:10.1007/s11882-025-01232-7 · Cited by 2
“ILC2s also persist for weeks following In vitro and some in vivo models like Alzheimer’s disease, TREM2 activation suppresses inflammatory cytokine pro - duction [95– 97 ].”
TREM2 and APOE are dispensable for microglial clearance of dying neurons revealed by in vivo imaging
Rai, A., Damisah, E. C., Hill, R., Tong, L., & Grutzendler, J. (2025) · iScience · doi:10.1016/j.isci.2025.114559 · Cited by 3
Translational Research in Stem Cell Treatment of Neuromuscular Diseases
Orbay, H., & Mizuno, H. (2012) · ISRN Stem Cells · doi:10.1155/2013/947329 · Cited by 2
“TREM2-transduced BM-derived myeloid precursor cells Mouse Limited tissue destruction and facilitated repair [105]”
BackgroundTissue Remodeling and Repair During Type 2 Inflammation
Chan, A. J., Jang, J. C., & Nair, M. G. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2911-5_7 · Cited by 3
Boettcher, C. (2007) · Asian Biomedicine · doi:10.5372/abm.v1i3.126 · Cited by 2
“cells, facilitate repair and resolution of inflammation within the CNS by clearance of cellular debris during EAE [77].”
BackgroundBrunois, C., & Ris, L. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_9 · Cited by 2
Microglia Colonization Associated with Angiogenesis and Neural Cell Development
Harry, G. J. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_10 · Cited by 2
Developmental Vascularization, Neurogenesis, Myelination, and Astrogliogenesis
Harry, G. J., & Pont‐Lezica, L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1429-6_8 · Cited by 3
TRAPC : A novel Triggering Receptor expressed on Antigen Presenting Cells
van der Holst, R. (2007) · Figshare · Cited by 2
Coelho, I., Duarte, N., Macedo, M. P., & Penha‐Gonçalves, C. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/857078 · Cited by 2
Gene therapy in neurodegenerative disorders
Ali, H. T., Sula, I., Elrefaey, A., Ashour, Y., Eltaras, M. M., Mohamed, H., & Meshref, M. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00036-1 · Cited by 1
Harnessing the microbiome to regulate myeloid TREM2 expression and innate immune responses
Mihori, S., Nichols, F. C., Jellison, E. R., Blesso, C. N., Graziano, V. R., Rathinam, V. A. K., & Clark, R. B. (2026) · ImmunoHorizons · doi:10.1093/immhor/vlaf073 · Cited by 1
“26 In the present study, our goals were to further document the potential disease relevance of our findings by establishing (1) that microbiome-derived S/G lipids can regulate the proinflammatory responses of macrophages that are activated and found in sites of inflammation; and (2) that…”
Fissolo, N., Benkert, P., Vilaseca, A., Blanco, Y., Hegen, H., Berek, K., Miralles, F. C. P., Rejdak, K., Villar, L. M., Monreal, E., et al. (2026) · European Journal of Neurology · doi:10.1111/ene.70480 · Cited by 1
Microglial Function in MS Pathology
Kilpatrick, T. J., & Jokubaitis, V. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2218-1_3 · Cited by 1
Mikroglia im Kontext der Multiplen Sklerose
Hoepner, R., Gold, R., & Faissner, S. (2014) · Nervenheilkunde · doi:10.1055/s-0038-1627744 · Cited by 1
“Die Phagozytose von Myelin und apoptotischen Zellen durch Mikroglia kann über den „Triggering receptor expressed on myeloid cells 2“ (TREM2) gesteigert werden, wie mittels TREM2 transduzierter myeloischer Vorläuferzellen gezeigt werden konnte (27).”
BackgroundTakahashi, K. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12479 · Cited by 1
“When TREM2-transduced bone marrow-derived myeloid precursor cells were injected intravenously into experimental autoimmune encephalomyelitis mice, these cells facilitated the repair within the experimental autoimmune encephalomyelitis lesions in the murine central nervous system through clearance of cellular debris.(2…”
BackgroundResultSelf-citationHoogland, I. C. M., Yik, J., Westhoff, D., Engelen-Lee, J.-Y., Seron, M. V., Man, W. K., Houben-Weerts, J. H. P. M., Tanck, M. W. T., van Westerloo, D. J., van der Poll, T., et al. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136894 · Cited by 1
“The first pathway regulates phagocytosis, were increased expression of TREM2 on microglia enhances phagocytic pathways and shifts microglia toward a neuroprotective function [7-9].”
BackgroundNeurotropic murine coronavirus mediated demyelination: Factors dampening pathogenesis
Hwang, M., & Bergmann, C. C. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578382 · Cited by 1
Gene therapy of multiple sclerosis
Furlan, R., Maiorino, C., Gatta, A. T., Ruffini, F., & Martino, G. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0165-8_5 · Cited by 1
“We already described the use of myeloid precursors to deliver a tolerogenic signal [45], or to induce a ‘protective’ phenotype to microglial cells [ 51 ].”
BackgroundMethodTrem2 Variants and Risk of Alzheimer’s Disease
Andres, P. M. D. (2014) · Brain Disorders & Therapy · doi:10.4172/2168-975x.1000127 · Cited by 1
“Increased expression of TREM2 on microglia is coupled to enhanced phagocytic pathways and promotes the alternative activation state of microglia, which is thought to be protective [6-8].”
Microglial Biology and Physiology
Butovsky, O., Madore, C., & Weiner, H. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_13 · Cited by 2
Ikezu, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_16 · Cited by 1
Mild Cognitive Impairment and Early Dementia
Damasceno, B. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-57267-9_20 · Cited by 1
Ikezu, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_30 · Cited by 1
Iizasa, E., Chuma, Y., Uematsu, T., Kubota, M., Kawaguchi, H., Umemura, M., Toyonaga, K., Kiyohara, H., Yano, I., Colonna, M., et al. (2020) · doi:10.21203/rs.3.rs-37581/v1 · Cited by 1
Carbajosa, G., Malki, K., Lawless, N., Wang, H., Ryder, J. W., Wozniak, E., Wood, K., Mein, C. A., Hodgkinson, A., Dobson, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.16.452732 · Cited by 1
TREM2 and APOE do not modulate phagocytic clearance of dying cells in the live mammalian brainPreprint
Damisah, E. C., Rai, A., Hill, R., Тонг, Л., & Grutzendler, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.17.533222 · Cited by 1
“In vivo studies in mice with Trem2 deficiency have only showed subtle differences in myelin phagocytosis and remyelination following extensive demyelination (Hsieh et al., 2009; Takahashi et al., 2007; Takahashi et al., 2005; Wang et al., 2015).”
BackgroundLee, C. Y. D., Rocha, A. J. D. L., Inouye, K., Langfelder, P., Daggett, A., Gu, X., Jiang, L.-L., Pamonag, Z., Vaca, R., Richman, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.03.551881 · Cited by 1
“TREM2 promotes microglial phagocytosis of several substrates, including apoptotic neurons [12], Aβ [50] and myelin debris [51].”
BackgroundNovel Multiple Sclerosis Predisposing Genetic Variants Outside the HLA Region
Kallio, S. (2009) · Työväentutkimus Vuosikirja · Cited by 1
Effects of Macrophages and Monocytes in Remyelination of the CNS
Natrajan, M. S., Bielekova, B., & Franklin, R. J. M. (2015) · Wiley eBooks · doi:10.1002/9781118732748.ch13
P2‐030: INVESTIGATING THE ROLE OF CLU, PICALM, AND CR1 IN ALZHEIMER'S DISEASE
Lord, J., Turton, J. C., Braae, A., Barber, I., Medway, C., Brown, K. S., & Morgan, K. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.703
NLRP 3 “inflammasome” plays a central role in “inflammatory” demyelination of multiple sclerosis
Yamamura, T. (2013) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12082
“NLRP3 inflammasome truly detrimental or beneficial for progression of inflammatory demyelination? The rapid clearance of damaged cellular debris by infiltrating phagocytes is a fundamental process to limit tissue damage.(7) In this regard, it needs to be clarified if anti-inflammatory/immunoregulatory M2 microglia can…”
BackgroundKiialainen, A. (2007) · Työväentutkimus Vuosikirja
Diabetes Pathogenesis - Role of Natural Killer Cells, T Cells and a Novel Neuropeptide
Brauner, H. (2010) · Figshare
Reviewsignaling in HIV-1 infection
Herbein, G., Gras, G. S., Khan, K. A., & Abbas, W. (2010)
Einfluss des immunsuppressiven Peptids von HIV-1 auf die Genexpression in humanen Immunzellen
Ryu, H. (2009) · Publication server of the Robert Koch Institute (Robert Kock Institute) · doi:10.25646/5309
Neurodegenerative disease and TREM2
Takahashi, K. (2014) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.54.1122
Self-citationDefining microglial phenotypic diversity and the impact of ageing
Grabert, K. (2015) · ERA
Microglia: Features of Polarization and Aging
Harry, G. J., & McPherson, C. A. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-33486-8_3
Szabó, M. (2016) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.2827
Wang, E., & Christiano, A. M. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.03.1376
Intraspinal Delivery of Recombinant AAV-Mediated Interleukin-10 Modifies Disease in ALS Mice
Chakrabarty, P., & Ayers, J. I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809813-4.00011-9
Doroshenko, E. R. (2019) · TSpace (University of Toronto)
Koch, B. M. E. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7716
“TREM2 is a cell Introduction 11| P a g e surface marker expressed by myeloid cells, where it regulates phagocytosis by activating DAP12 which is an AD risk gene as well (Kleinberger et al., 2014; Takahashi et al., 2007).”
BackgroundDistinct Myeloid Cell Subsets with Divergent Functions in Central Nervous System Autoimmunity
Giles, D. A. (2020) · Deep Blue (University of Michigan)
Genetics of Multiple Sclerosis
Leppä, V. (2013) · Työväentutkimus Vuosikirja
Immunopharmacology of Alzheimer’s disease
Nissar, K., Firdous, P., Ali, S., & Hussain, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90053-9.00014-2
Myelin pruning by microglia during development
Weikert, U. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7415
TREM-2 promotes neural repair in animal model of multiple sclerosis
(2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0547
Emerging Roles of TREM2 in Neurodegenerative Diseases
Kabir, M. T. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_7
Qiu, Z., Wang, H., Qu, M., Zhu, S., Zhang, H., Liao, Q., & Miao, C. (2022) · Research Square · doi:10.21203/rs.3.rs-2064325/v1
Etebar, F. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.244774
Ikezu, T. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_22
Sarlus, H., Guo, Y., Bencina, S., Zhu, K., Joshua, V., Virgilio, G. A., Cheng, Y., Lin, J., Min, J.-H., Benito‐Cuesta, I., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.14.659704
“…could effectively clear myelin debris, a key function mediated by immunosuppressive macrophages to facilitate remyelination and tissue repair 55,56 , we exposed myeloid cells isolated from PBS-or AEC-treated brains at the EAE peak to pHrodo-labelled myelin debris for 60 min ex vivo ( Figure…”
Guadalupi, L., Vanni, V., Balletta, S., Caioli, S., Vito, F. D., Fresegna, D., Sanna, K., Nencini, M., Donninelli, G., Volpe, E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25824812
Guadalupi, L., Vanni, V., Balletta, S., Caioli, S., Vito, F. D., Fresegna, D., Sanna, K., Nencini, M., Donninelli, G., Volpe, E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26720076
Metadata
- Authors
- Takahashi, K., Prinz, M., Stagi, M., Chechneva, O., & Neumann, H.
- Affiliations
- University of Bonn (DE)
- Universitätsmedizin Göttingen (DE)
- Corresponding author
- Neumann, Harald
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-04-10
- Volume
- 4
- Issue
- 4
- Pages
- e124
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC1851623
- OpenAlex
- W2116226263
- Cited by
- 414
- References
- 51
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 28 · 2023: 18 · 2022: 19 · 2021: 22 · 2020: 19 · 2019: 23 · 2018: 23 · 2017: 28 · 2016: 24 · 2015: 35 · 2014: 32 · 2013: 34 · 2012: 16
- FWCI
- 13.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Funders
- Deutsche Forschungsgemeinschaft (SFB 704)
- Gemeinnützige Hertie-Stiftung
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- TREM2, multiple sclerosis, experimental autoimmune encephalomyelitis, myeloid precursors, microglia, phagocytosis, myelin debris clearance, demyelination, axonal injury, neuroinflammation, neurorepair, gene therapy, bone marrow-derived cells, anti-inflammatory cytokines
- MeSH terms
- Animals, Cell Differentiation, Cell Movement, Cells, Cultured, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental, Female, Flow Cytometry, Gene Expression Regulation, Genes, Synthetic, Genetic Vectors, Humans, Membrane Glycoproteins, Mice, Inbred C57BL, Monocytes, Multiple Sclerosis, Neurons, Phagocytosis, Promoter Regions, Genetic, Receptors, Immunologic, Transduction, Genetic, Genetic Therapy, Lentivirus, Granulocyte-Macrophage Colony-Stimulating Factor, Cytokines, Interleukin-10, Apoptosis, Microglia, Genes, Reporter, Hematopoietic Stem Cell Transplantation, Cell Lineage, Myeloid Cells, Mice, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.